Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Human Study on Commercial Cellobiose as a Potential Prebiotic Candidate

NCT07097389 is registered in ClinicalTrials.gov with Manxi Huang as lead sponsor.

NCT NCT07097389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07097389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Human Study on Commercial Cellobiose as a Potential Prebiotic Candidate
Lead sponsor
Manxi Huang
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2024
Completion date
June 1, 2025
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

as a preliminary study, healthy population's gut microbiota is studied to see if cellobiose supplementation is altering the microbial community or not, gut -microbiota